Cycloalkyl substituted pyrazolopyrimidines having activity against RSV
US11491157B2 · kind B2 · utility
0Cited by
17References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 30, 2019 |
| Grant date | Nov 8, 2022 |
| Priority date | — |
| Expiry date | Feb 1, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns compounds of formula (I) having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (RSV). The invention further concerns pharmaceutical compositions comprising these compounds and the compounds for use in the treatment of respiratory syncytial virus infection. (Formula I).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.